WHO ICTRP trial
A Chinese herbal medicine (Xilei-san) for mild/moderate ulcerative proctitis
ISRCTN56157078 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN56157078 |
|---|---|
| Public title | A Chinese herbal medicine (Xilei-san) for mild/moderate ulcerative proctitis |
| Scientific title | A Chinese herbal medicine (Xilei-san) for mild/moderate ulcerative proctitis: a randomised, placebo controlled study |
| Primary sponsor | Zhengzhou University (China) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | China |
| Conditions | Mild or moderate ulcerative proctitis Digestive System Ulcerative (chronic) proctitis |
| Interventions | Dexamethasone was formulated as 5 mg/60 ml and Xilei-San as 1000 mg/60 ml (Beijing Tong Ren Tang Ltd., Co., Beijing, China). Patients were instructed to take the formulation as enema once a day for 4 weeks and monitored the usage of drug… |
| Registration date | Sep 12, 2011 |
| Target size | 35 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: